NeuroSense Therapeutics Ltd. Company Profile
NASDAQ: NRSNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NeuroSense Therapeutics at a glance
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Herzliya, Israel. NeuroSense Therapeutics is led by Mr. Alon Ben-Noon and employs about 17 people. The company's shares have traded publicly since 2021.
At a market capitalization of $6.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001875091, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does NeuroSense Therapeutics do?
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- NeuroSense Therapeutics Ltd.
- Ticker
- NASDAQ: NRSN
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Alon Ben-Noon
- Employees
- 17
- Headquarters
- Building B, Herzliya, Israel
- Phone
- 972 9 799 6183
- Website
- neurosense-tx.com
- IPO year
- 2021
- Market cap
- $6.94M
- SEC CIK
- 0001875091
Companies similar to NeuroSense Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LEXXLexaria Bioscience Corp. | 3.32 | -1.19% | $6.99M | vs NRSN |
| XCURExicure Inc. | 1.05 | +3.96% | $6.87M | vs NRSN |
| TRAWTraws Pharma Inc. | 0.4452 | -7.31% | $6.84M | vs NRSN |
| ACXPAcurx Pharmaceuticals Inc. | 1.27 | +1.60% | $7.06M | vs NRSN |
| ENVBEnveric Biosciences Inc. | 1.45 | -4.61% | $6.49M | vs NRSN |
| ALZNAlzamend Neuro Inc. | 1.34 | 0.00% | $6.47M | vs NRSN |
| INMInMed Pharmaceuticals Inc. | 1.36 | +2.26% | $7.47M | vs NRSN |
| SKYESkye Bioscience Inc. | 1.69 | +0.60% | $7.48M | vs NRSN |